UNSPSC 51433402: Moexipril

This classification denotes an ace inhibitor with the molecular formula C27H34N2O7, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier WT87C52TJZ, chemically known as (3s)-2-((2s)-n-((1s)-1-carboxy-3-phenylpropyl)alanyl)-1,2,3,4-tetrahydro-6,7-dimethoxy-3-isoquinolinecarboxylic acid, 2-ethyl ester but generally known as moexipril, which bears US NIH Compound Identifier 91270. European Medicines Agency schedules Moexipril in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09030MIG.

UNSPSC 51433402 Moexipril, a Commodity code, classifies prescription medications for emergency medical use, but the recent state and local activity under this code reflects a much broader procurement of advanced life support drugs rather than moexipril specifically. State and local health and public-safety agencies use this code to procure injectable medications for emergency medical services, including vasopressors, cardiac agents, and other acute-care drugs that paramedics and fire rescue personnel administer in the field. The City of Tampa's recent solicitation for advanced life support medications illustrates the actual scope: fire rescue services are buying multiple lines of emergency injectables (labetalol, epinephrine, adenosine, diltiazem) as bundles, often under a single contract with firm pricing, nine-month minimum shelf life, rapid delivery windows, and the option to renew or extend. Issuing bodies are typically municipal fire departments and county emergency medical services, which treat these procurements as operational goods requiring sealed bids and responsive-vendor management rather than as specialty pharmaceutical items.

The Tampa Fire Rescue procurement (City of Tampa Purchasing Department, IFB 26P00188, due April 8, 2026) represents the primary visible recent activity under this code. The estimated contract value is $40,000.00, and the solicitation included a Small Local Business Enterprise sheltered-market designation with a 5 percent bid discount capped at $10,000. Geographic activity appears concentrated in Florida, though the source does not support a characterization of other states or regions where moexipril or related advanced life support medications are being procured at the state or local level. No other recent opportunities appear in the record.